Quirante, Azriel Clyde C.
HRN: 26-24-86 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2024
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
11/22/2024
11/29/2024
PO
2ml
BID
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes